Find clinical trials for Fatty Liver. Search for Fatty Liver clinical trials in different cities and states across the United States.
Fatty liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), occurs when fat builds up in the liver. This condition can lead to inflammation, liver damage, and more serious complications if untreated.
Clinical trials for fatty liver explore innovative treatments aimed at reducing liver fat and preventing progression, providing participants early access to transformative treatment options.
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: South Dartmouth MA, New Haven CT, New York NY,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
for
Hepatic Steatosis, NAFLD, Adolescent Obesity
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 13 - 18
Code: NCT05935826
Phase3, Recruiting
Active & Responsive
Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD